Skip to main content

Advertisement

SpringerLink
Log in

Assessment of G6PD screening program in premature infants in a NICU

  • Original Article
  • Published:
Journal of Perinatology Submit manuscript

Abstract

Objective:

Targeted screening for glucose-6-phosphate dehydrogenase deficiency (G6PDdef) using fluorescent spot test (FST) is done in our newborn nursery (NN) and now in our NICU. Premature infants have higher G6PD levels than term infants. FST may result in under diagnosis of G6PDdef in preterms. We sought to determine if FST is appropriate for diagnosis of G6PDdef at<35 weeks and assess screening in NICU.

Study Design:

Retrospective chart review of male, inborn infants<35 weeks in NICU from 2008 to 2011. Difference in G6PDdef incidence<5% between NN and NICU was acceptable for equivalence.

Results:

Out of 679 subjects, 442 were screened for G6PDdef and 11.3% had abnormal results. Binomial testing comparing 11.3% (95% confidence interval (CI) 8.5 to 14.6) incidence of G6PDdef in NICU and reported incidence in NN (11%) demonstrated no difference. 12.2% of Black/African American males were not screened.

Conclusion:

FST is appropriate for screening all at-risk newborns. A number of at-risk premature males were not screened.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Nikhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E . The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cell Mol Dis 2009; 42: 267–278.

    Article  Google Scholar 

  2. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Org 1989; 67: 601–611.

    Google Scholar 

  3. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24: 650–662.

    Article  Google Scholar 

  4. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN . International committee of standardization in haematology: recommneded screening test for gluose-6-phosphate dehydroganase (G-6-PD) deficiency. Brit J Haematol 1979; 43: 465–467.

    Article  CAS  Google Scholar 

  5. Wolf BHM, Weening RS, Schutgens RBH, van Noorden CJF, Vogels IMC, Nagelkerke NJD . Detection of glucose-6-phosphate dehydrogenase deficiency in erythrocytes: a spectrophotometric assay and a fluorescent spot test compared with a cytochemical method. Clin Chim Acta 1987; 168: 129–136.

    Article  CAS  Google Scholar 

  6. Roca-Felterer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A et al. Field trial evaluation of the performance of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One 2014; 9: e116143.

    Article  Google Scholar 

  7. Kaplan M, Leiter C, Hammerman C, Rudensky B . Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the newborn period. Clin Chem 1997; 43: 1236–1237.

    CAS  Google Scholar 

  8. Nock ML, Johnson EM, Di Fiore JM, Fitzgerald S, Sandhaus LM, Walsh MC . Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States. J Perinatol 2011; 31: 112–117.

    Article  CAS  Google Scholar 

  9. Ainoon O, Alawiyah A, Yu YH, Cheong SK, Hamidah NH, Boo NY et al. Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partial-deficiency females. Southeast Asian J Trop Med Public Health 2003; 34 (2): 405–414.

    CAS  Google Scholar 

  10. Ko CH, Wong RP-O, Ng PC, Li K, Chui KM, Yuen PM-P et al. Oxidative challenge and glucose-6-phosphate dehydrogenase activity of preterm and term neonatal red blod cells. Neonatology 2009; 96: 96–101.

    Article  CAS  Google Scholar 

  11. Mesner O, Hammerman C, Goldschmidt D, Rudensky B, Bader D, Kaplan M . Glucose-6-phosphate dehydrogenase activity in male premature and term neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89: F555–F557.

    Article  CAS  Google Scholar 

  12. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114 (1): 297–316.

    Article  Google Scholar 

  13. Watchko JF, Maisels MJ . Enduring controversies in the management of hyperbilirubinemia in preterm neonates. Semin Fetal Neonat Med 2010; 15: 136–140.

    Article  Google Scholar 

  14. Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK . Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol 2013; 33: 499–504.

    Article  CAS  Google Scholar 

  15. Kaplan M, Beutler E, Vreman HJ, Hammerman C, Levy-Lahad E, Renbaum P et al. Neonatal hyperbilirubinemia in glucose-6-phosphate deydrogenase-deficient heterozygotes. Pediatrics 1999; 104: 68–74.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, Oregon Health and Science University, Doernbecher Children’s Hospital, Portland, OR, USA

    R Lam

  2. Center for Clinical Investigation, Case Western Reserve University, Cleveland, OH, USA

    H Li

  3. Division of Neonatology, Department of Pediatrics, University Hospitals Case Medical Center Rainbow Babies and Children’s Hospital, Cleveland, OH, USA

    M L Nock

Authors
  1. R Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M L Nock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M L Nock.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lam, R., Li, H. & Nock, M. Assessment of G6PD screening program in premature infants in a NICU. J Perinatol 35, 1027–1029 (2015). https://doi.org/10.1038/jp.2015.129

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2015.129

  • Springer Nature America, Inc.

Search

Navigation